IP Verse

Richter Gedeon Nyrt. opposition analysis

COMPANY ANALYSIS

Patent:

Grant Date:

Dec 7, 2022

Title:

Industrial Process For The Preparation Of High Purity Estetrol

Oppositions:

Patent:

Grant Date:

Dec 30, 2020

Title:

Trans-4-{2-[4-(2,3-Dichlorophenyl)-Piperazin-1-Yl]-Ethyl}-N,N-Dimethylcarbamoyl-Cyclohexylamine For Treating Negative Symptoms Of Schizophrenia

Oppositions:

Patent:

Grant Date:

Apr 24, 2019

Title:

Method For The Production Of Polypeptides

Oppositions:

Patent:

Grant Date:

Sep 19, 2018

Title:

Pharmaceutical Anti-Tnf-Alpha Antibody Formulation

Oppositions:

Patent Number	Grant Date	Title	Total Oppositions
EP3877395	Dec 7, 2022	Industrial Process For The Preparation Of High Purity Estetrol	1
EP2925324	Dec 30, 2020	Trans-4-{2-[4-(2,3-Dichlorophenyl)-Piperazin-1-Yl]-Ethyl}-N,N-Dimethylcarbamoyl-Cyclohexylamine For Treating Negative Symptoms Of Schizophrenia	2
EP2828396	Apr 24, 2019	Method For The Production Of Polypeptides	1
EP3212667	Sep 19, 2018	Pharmaceutical Anti-Tnf-Alpha Antibody Formulation	3

BIOGEN INC.

INDUSTRIALE CHIMICA S.R.L.

KRKA, D.D., NOVO MESTO

Feel free to send us a message here and we will get back to you